Disclosure of and labeling requirements regarding certain ingredients in menstrual products. (FE)
Impact
The proposed legislation could significantly influence state laws related to product safety and consumer protection. By implementing these disclosure requirements, AB1213 aims to enhance public awareness about the contents of menstrual products, potentially driving manufacturers to reformulate their products to eliminate harmful ingredients. This could lead to improved health outcomes for consumers and contribute to a broader movement for transparency in consumer goods. Retailers would also face new responsibilities to provide accurate ingredient information, fostering a change in how menstrual products are marketed and sold in Wisconsin.
Summary
Assembly Bill 1213 focuses on the disclosure and labeling requirements for ingredients used in menstrual products. It mandates that the Department of Agriculture, Trade and Consumer Protection (DATCP) create and maintain a list of ingredients that pose health risks, such as carcinogens or reproductive toxins. Manufacturers are required to disclose any such ingredients in their products sold or distributed within the state and are also obligated to update their ingredient lists with DATCP whenever changes occur. The bill aims to ensure greater transparency and protect consumers from harmful substances in menstrual products.
Contention
Some points of contention surrounding AB1213 may arise from differing views on the implications of these requirements on manufacturers. Proponents argue that increased transparency is vital for consumer safety and empowerment, allowing individuals to make informed choices regarding their health. Critics, however, might express concerns over the burden of compliance costs for manufacturers, particularly small businesses that may struggle to navigate the reporting and labeling protocols. Additionally, there could be discussions related to how these regulations align with existing laws regarding consumer rights and product labeling within the state.
Requirements for products containing lead or cadmium modified, sale of menstrual products containing arsenic or chemicals of high concern prohibited, labeling and testing for menstrual products required, and rulemaking required.